Chugai Pharmaceutical Co Ltd
XMUN:CUP
Chugai Pharmaceutical Co Ltd
XMUN:CUP
Price:
37.94
EUR
0.18%
Market Cap:
€62.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chugai Pharmaceutical Co Ltd
XMUN:CUP
|
JP |
|
America Movil SAB de CV
BMV:AMXB
|
MX |
|
K
|
Kyushu Railway Co
SWB:KRH
|
JP |
|
Flameret Inc
OTC:FLRE
|
US |
|
S
|
Synopsys Inc
LSE:0LBP
|
US |
|
A
|
Amdocs Ltd
XMUN:AOS
|
GG |
|
M
|
Matsui Securities Co Ltd
OTC:MAUSY
|
JP |
|
G
|
GCL New Energy Holdings Ltd
SWB:TJI
|
HK |
|
F
|
First Pacific Co Ltd
OTC:FPAFF
|
HK |
|
Tokyo Ohka Kogyo Co Ltd
OTC:TOKCF
|
JP |
|
M
|
Mercanto Holdings Inc
OTC:TGSHF
|
CA |
|
Pipehawk PLC
LSE:PIP
|
UK |
|
H
|
Haohua Chemical Science & Technology Corp Ltd
SSE:600378
|
CN |
|
O
|
Otobrite Electronics Inc
TPEX:2256
|
TW |
|
Catenon SA
MAD:COM
|
ES |
|
P
|
Prothena Corporation PLC
F:0PT
|
IE |
|
V
|
Vestas Wind Systems A/S
DUS:VWSB
|
DK |
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 491.8B | 534.2B | 579.8B | 686.2B | 786.9B | 999.8B | 1.3T | 1.1T | 1.2T | 1.3T | |
| (247.9B) | (254.2B) | (262.8B) | (264.7B) | (273.5B) | (337.7B) | (476.3B) | (412.7B) | (337.9B) | (352.9B) | |
| 243.8B | 280B | 316.9B | 421.5B | 513.5B | 662.1B | 783.5B | 698.7B | 832.8B | 905.1B | |
| (167B) | (181.1B) | (192.6B) | (206.9B) | (211.3B) | (233.8B) | (249.5B) | (253.8B) | (285B) | (293.7B) | |
| (81.9B) | (88.1B) | (93.4B) | (100.7B) | (93B) | (100.8B) | (99.6B) | (111.9B) | (109.7B) | (116.3B) | |
| (85B) | (92.9B) | (99.2B) | (104.7B) | (116.6B) | (131.3B) | (148.1B) | (169.1B) | (176.7B) | (185.7B) | |
| — | — | — | (1.5B) | (1.7B) | (1.8B) | (1.8B) | (1.4B) | (818m) | (373m) | |
| (1m) | — | 1m | — | — | — | (63m) | 28.6B | 2.3B | 8.6B | |
| 76.9B | 98.9B | 124.3B | 214.5B | 302.2B | 428.2B | 534B | 444.9B | 547.8B | 611.4B | |
| 1.3B | 4m | 444m | 519m | (1.6B) | 56m | 769m | 4.2B | 323m | (3.4B) | |
| 8m | 5m | 5m | 27m | 34m | 48m | 58m | 81m | 94m | 425m | |
| (160m) | (97m) | — | (3.9B) | (953m) | (6.3B) | (641m) | (5.8B) | (5.8B) | (12.6B) | |
| (3.5B) | (1.8B) | (3.3B) | (3.2B) | (1.5B) | (2.6B) | (2.9B) | 407m | 709m | 2.3B | |
| 74.4B | 97B | 121.4B | 207.9B | 298.2B | 419.4B | 531.2B | 443.8B | 543B | 597.8B | |
| (20.1B) | (23.5B) | (28.4B) | (50.3B) | (83.5B) | (116.4B) | (156.7B) | (118.3B) | (155.7B) | (163.8B) | |
| 54.4B | 73.5B | 93.1B | 157.6B | 214.7B | 303B | 374.4B | 325.5B | 387.3B | 434B | |
| (780m) | (827m) | (591m) | — | — | — | — | — | — | — | |
| 53.6B | 72.7B | 92.5B | 157.6B | 214.7B | 303B | 374.4B | 325.5B | 387.3B | 434B | |
| 32.66 | 44.28 | 56.27 | 95.81 | 130.53 | 184.17 | 227.57 | 197.80 | 235.36 | 263.73 |
Diversified science businesses with resilient margins and recurring cash generation
A diversified pharma platform with durable cash generation and volatile reported earnings
A mature diversified portfolio with recurring cash generation and volatile reported earnings
A profitable specialty-led pharma platform with rising reinvestment and durable cash generation
Continue CUP Research
Other Chugai Pharmaceutical Co Ltd listings: